OPK insider buying

4 cluster buys

OPKO HEALTH, INC. · Healthcare

When two or more insiders at OPKO HEALTH, INC. buy OPK on the open market around the same time, that clustered conviction is one of the highest-signal patterns in SEC filing data. Below is every cluster we've detected in OPK plus the full record of qualifying open-market buys, each parsed directly from Form 4 filings and linked back to the source on SEC EDGAR.

Clusters
4
Distinct insiders
4
Total bought
$8.0M
Market cap
$1.1B

Detected clusters

  • Aug 8 – Nov 21, 2025
    Detected Nov 21, 2025
    High conviction2 insiders
    Total bought
    $3.4M
    Market cap
    $1.1B
  • Mar 17 – Apr 10, 2025
    Detected Apr 10, 2025
    High conviction2 insiders
    Total bought
    $1.1M
    Market cap
    $1.2B
  • Jan 15 – Jan 17, 2025
    Detected Jan 17, 2025
    High conviction2 insiders
    Total bought
    $960.5K
    Market cap
    $1.2B

1 more cluster in OPK

Sign in free to see the full history, or go Pro for real-time alerts the moment new insider clusters form.

All notable open-market buys in OPK

Every open-market Form 4 purchase, newest first. Click an insider to see their full buying record across companies.

DateInsiderSharesPriceValueFiling
Mar 20, 2026
Director
10,000$1.14$11.4KSEC ↗
Nov 21, 2025
10% Owner
192,870$1.34$258.4KSEC ↗
Nov 21, 2025
10% Owner
191,490$1.33$254.7KSEC ↗
Nov 21, 2025
10% Owner
102,371$1.30$133.1KSEC ↗
Nov 21, 2025
10% Owner
89,375$1.33$118.9KSEC ↗
Nov 20, 2025
10% Owner
211,948$1.33$281.9KSEC ↗
Nov 20, 2025
10% Owner
161,818$1.34$216.8KSEC ↗
Nov 20, 2025
10% Owner
119,129$1.32$157.3KSEC ↗
Nov 19, 2025
10% Owner
198,904$1.32$262.6KSEC ↗
Nov 19, 2025
10% Owner
155,496$1.32$205.3KSEC ↗
Nov 18, 2025
10% Owner
212,608$1.28$272.1KSEC ↗
Nov 18, 2025
10% Owner
83,556$1.29$107.8KSEC ↗
Oct 31, 2025
Director, CEO & Chairman, 10% Owner
150,000$1.42$213.0KSEC ↗
Aug 8, 2025
Director, CEO & Chairman, 10% Owner
675,000$1.32$891.0KSEC ↗
Apr 10, 2025
Director, CEO & Chairman, 10% Owner
125,000$1.36$170.0KSEC ↗
Apr 8, 2025
10% Owner
125,000$1.48$185.0KSEC ↗
Apr 1, 2025
Director, CEO & Chairman, 10% Owner
100,000$1.65$165.0KSEC ↗
Mar 28, 2025
10% Owner
150,000$1.70$255.0KSEC ↗
Mar 17, 2025
10% Owner
200,000$1.74$348.0KSEC ↗
Feb 28, 2025
10% Owner
67,434$1.71$115.3KSEC ↗
Jan 28, 2025
10% Owner
47,537$1.47$69.9KSEC ↗
Jan 17, 2025
10% Owner
150,000$1.47$220.5KSEC ↗
Jan 15, 2025
Director, CEO & Chairman, 10% Owner
500,000$1.48$740.0KSEC ↗
Dec 13, 2024
10% Owner
125,000$1.60$200.0KSEC ↗
Dec 11, 2024
10% Owner
500,000$1.56$780.0KSEC ↗
6 earlier buys hidden — sign in free to see the full history.

More Healthcare stocks with insider cluster buys

All insider buying in Healthcare

OPK insider buying — FAQ

Are insiders buying OPK stock?
Yes — 4 distinct insiders have bought OPK (OPKO HEALTH, INC.) on the open market, including 4 cluster buys where two or more insiders bought within a rolling window. The most recent qualifying activity was Mar 20, 2026.
How much OPK stock have insiders bought?
Insiders have bought a combined $8.0M of OPK across 31 open-market purchases, based on SEC Form 4 filings.
What is an insider cluster buy in OPK?
A cluster buy is two or more distinct OPKO HEALTH, INC. insiders — officers, directors, or 10% owners — each buying OPK on the open market within a rolling window. OPK has 4 detected cluster buys to date.
Where does this OPK insider trading data come from?
Every figure is parsed directly from SEC Form 4 filings on EDGAR, and each purchase on this page links back to its original filing document.

How we track insider buying in OPK

We continuously poll SEC EDGAR for new Form 4 filings and parse every open-market purchase (transaction code P). A cluster is recorded when two or more distinct insiders — officers, directors, or 10% owners — each buy OPK within a rolling window. We track clusters at every company size, from micro-caps to mega-caps. Every figure on this page traces back to an official filing; open any row to jump straight to the source document. What counts as a cluster buy?

This page is informational and reflects public filing data. It is not investment advice or a recommendation regarding OPK.